• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

接受抗逆转录病毒治疗的HIV患者服用他汀类药物时的心肌梗死、中风及死亡率

Myocardial Infarction, Stroke, and Mortality in cART-Treated HIV Patients on Statins.

作者信息

Krsak Martin, Kent David M, Terrin Norma, Holcroft Christina, Skinner Sally C, Wanke Christine

机构信息

1Tufts Medical Center and Tufts University, Boston, Massachusetts.

2Predictive Analytics and Comparative Effectiveness (PACE) Center, Tufts Medical Center, Boston, Massachusetts.

出版信息

AIDS Patient Care STDS. 2015 Jun;29(6):307-13. doi: 10.1089/apc.2014.0309. Epub 2015 Apr 9.

DOI:10.1089/apc.2014.0309
PMID:25855882
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4516911/
Abstract

Despite combination antiretroviral therapy (cART), people living with HIV (PLWH) continue to have more systemic inflammation and metabolic disturbances than the general population. These risk factors for atherosclerosis and organ dysfunction may be ameliorated by statins. We retrospectively analyzed 438 cART treated PLWH from the Nutrition For Healthy Living (NFHL) cohort to determine the association between statins and myocardial infarction (MI), stroke, and all-cause mortality as a composite. We used Cox proportional hazards regression as our main analysis. The average age was 44 years, 32% were women, and 67 of the 438 subjects used statins. There was no association between statins and our composite endpoint in two separate models [1.26 (0.57-2.79) in statin history model and 0.93 (0.65-1.32) per year in statin duration model]. The composite outcome was significantly associated with CD4 count, age, and smoking status in both models. CD4 count remained significant even after exclusion of mortality from the composite (HR=0.88, p=0.02). Confounding control via propensity scoring and multiple imputations did not change the results. Statins did not have an effect on MI, stroke, and mortality. Interestingly, CD4 count appears to be an important predictor of these outcomes, even after exclusion of death from the composite.

摘要

尽管采用了抗逆转录病毒联合疗法(cART),但与普通人群相比,艾滋病毒感染者(PLWH)仍存在更多的全身炎症和代谢紊乱。他汀类药物可能会改善这些动脉粥样硬化和器官功能障碍的危险因素。我们对营养促进健康生活(NFHL)队列中438名接受cART治疗的PLWH进行了回顾性分析,以确定他汀类药物与心肌梗死(MI)、中风和全因死亡率这一综合指标之间的关联。我们将Cox比例风险回归作为主要分析方法。平均年龄为44岁,32%为女性,438名受试者中有67人使用他汀类药物。在两个独立模型中,他汀类药物与我们的综合终点之间均无关联[他汀类药物使用史模型中为1.26(0.57 - 2.79),他汀类药物使用时长模型中每年为0.93(0.65 - 1.32)]。在两个模型中,综合结局均与CD4细胞计数、年龄和吸烟状况显著相关。即使从综合指标中排除死亡率后,CD4细胞计数仍具有显著性(HR = 0.88,p = 0.02)。通过倾向评分和多重插补进行的混杂因素控制并未改变结果。他汀类药物对心肌梗死、中风和死亡率没有影响。有趣的是,即使从综合指标中排除死亡因素,CD4细胞计数似乎仍是这些结局的重要预测指标。

相似文献

1
Myocardial Infarction, Stroke, and Mortality in cART-Treated HIV Patients on Statins.接受抗逆转录病毒治疗的HIV患者服用他汀类药物时的心肌梗死、中风及死亡率
AIDS Patient Care STDS. 2015 Jun;29(6):307-13. doi: 10.1089/apc.2014.0309. Epub 2015 Apr 9.
2
Incidence of new stroke or new myocardial infarction or death in patients with severe carotid arterial disease treated with and without statins.接受和未接受他汀类药物治疗的严重颈动脉疾病患者中新发中风、新发心肌梗死或死亡的发生率。
Am J Cardiol. 2006 Nov 1;98(9):1170-1. doi: 10.1016/j.amjcard.2006.06.009. Epub 2006 Aug 31.
3
Statins reduce new-onset atrial fibrillation in a first-time myocardial infarction population: a nationwide propensity score-matched study.他汀类药物可降低首次心肌梗死人群新发房颤的发生率:一项全国性倾向评分匹配研究。
Eur J Prev Cardiol. 2014 Mar;21(3):330-8. doi: 10.1177/2047487312462804. Epub 2012 Sep 25.
4
Early statin initiation and outcomes in patients with acute coronary syndromes.急性冠状动脉综合征患者早期启动他汀治疗及其预后
JAMA. 2002 Jun 19;287(23):3087-95. doi: 10.1001/jama.287.23.3087.
5
Concomitant administration of clopidogrel with statins or calcium-channel blockers: insights from the TRITON-TIMI 38 (trial to assess improvement in therapeutic outcomes by optimizing platelet inhibition with prasugrel-thrombolysis in myocardial infarction 38).氯吡格雷与他汀类药物或钙通道阻滞剂联合应用:来自 TRITON-TIMI 38 试验(评估通过优化普拉格雷抑制血小板治疗改善心肌梗死溶栓治疗 38 预后的试验)的见解。
JACC Cardiovasc Interv. 2013 Dec;6(12):1275-81. doi: 10.1016/j.jcin.2013.06.014. Epub 2013 Nov 13.
6
Statins After Myocardial Infarction in the Oldest: A Cohort Study in the Clinical Practice Research Datalink Database.心肌梗死后老年患者应用他汀类药物治疗:临床实践研究数据链数据库中的一项队列研究。
J Am Geriatr Soc. 2020 Feb;68(2):329-336. doi: 10.1111/jgs.16227. Epub 2019 Oct 24.
7
Statins, risk of diabetes, and implications on outcomes in the general population.他汀类药物、糖尿病风险及对普通人群结局的影响。
J Am Coll Cardiol. 2012 Oct 2;60(14):1231-8. doi: 10.1016/j.jacc.2012.05.019. Epub 2012 Aug 8.
8
Is Impact of Statin Therapy on All-Cause Mortality Different in HIV-Infected Individuals Compared to General Population? Results from the FHDH-ANRS CO4 Cohort.与普通人群相比,他汀类药物治疗对HIV感染者全因死亡率的影响是否不同?来自FHDH-ANRS CO4队列的结果。
PLoS One. 2015 Jul 22;10(7):e0133358. doi: 10.1371/journal.pone.0133358. eCollection 2015.
9
Statins after recent stroke reduces recurrence and improves survival in an aging Mediterranean population without known coronary heart disease.近期卒中后使用他汀类药物可降低复发风险并改善无已知冠心病的老龄化地中海人群的生存。
J Clin Pharm Ther. 2012 Aug;37(4):441-7. doi: 10.1111/j.1365-2710.2011.01318.x. Epub 2011 Nov 7.
10
A combination of statins and beta-blockers is independently associated with a reduction in the incidence of perioperative mortality and nonfatal myocardial infarction in patients undergoing abdominal aortic aneurysm surgery.他汀类药物和β受体阻滞剂联合使用与腹主动脉瘤手术患者围手术期死亡率和非致命性心肌梗死发生率的降低独立相关。
Eur J Vasc Endovasc Surg. 2004 Oct;28(4):343-52. doi: 10.1016/j.ejvs.2004.07.008.

引用本文的文献

1
Characterization and stratification of risk factors of stroke in people living with HIV: A theory-informed systematic review.HIV感染者中风风险因素的特征与分层:一项基于理论的系统评价
BMC Cardiovasc Disord. 2025 May 27;25(1):405. doi: 10.1186/s12872-025-04833-2.
2
Hypertension among people living with human immunodeficiency virus in sub-Saharan Africa: a systematic review and meta-analysis.撒哈拉以南非洲地区艾滋病毒感染者中的高血压:系统评价和荟萃分析。
Sci Rep. 2024 Jul 23;14(1):16858. doi: 10.1038/s41598-024-67703-5.
3
Role of Statin in Reducing Cardiovascular Diseases in Human Immunodeficiency Virus (HIV) Patients: A Systematic Review.他汀类药物在降低人类免疫缺陷病毒(HIV)患者心血管疾病中的作用:一项系统评价。
Cureus. 2022 Oct 21;14(10):e30549. doi: 10.7759/cureus.30549. eCollection 2022 Oct.
4
Influence of Statin Therapy on the Incidence of Cardiovascular Events, Cancer, and All-Cause Mortality in People Living With HIV: A Meta-Analysis.他汀类药物治疗对HIV感染者心血管事件、癌症发病率及全因死亡率的影响:一项荟萃分析。
Front Med (Lausanne). 2021 Nov 8;8:769740. doi: 10.3389/fmed.2021.769740. eCollection 2021.
5
Consistent use of lipid lowering therapy in HIV infection is associated with low mortality.在 HIV 感染中持续使用降脂治疗与低死亡率相关。
BMC Infect Dis. 2021 Feb 5;21(1):150. doi: 10.1186/s12879-021-05787-4.
6
HIV-associated cardiovascular disease: importance of platelet activation and cardiac fibrosis in the setting of specific antiretroviral therapies.与人类免疫缺陷病毒(HIV)相关的心血管疾病:特定抗逆转录病毒疗法背景下血小板活化和心脏纤维化的重要性
Open Heart. 2018 Jul 11;5(2):e000823. doi: 10.1136/openhrt-2018-000823. eCollection 2018.
7
Statin use and all-cause mortality in people living with HIV: a systematic review and meta-analysis.他汀类药物的使用与 HIV 感染者的全因死亡率:系统评价和荟萃分析。
BMC Infect Dis. 2018 Jun 5;18(1):258. doi: 10.1186/s12879-018-3162-1.
8
Benefits and Risks of Statin Therapy in the HIV-Infected Population.他汀类药物治疗在HIV感染人群中的益处与风险
Curr Infect Dis Rep. 2018 May 26;20(8):20. doi: 10.1007/s11908-018-0628-7.
9
Evaluation of Statin Eligibility, Prescribing Practices, and Therapeutic Responses Using ATP III, ACC/AHA, and NLA Dyslipidemia Treatment Guidelines in a Large Urban Cohort of HIV-Infected Outpatients.使用 ATP III、ACC/AHA 和 NLA 血脂异常治疗指南评估大样本城市 HIV 感染门诊患者的他汀类药物适用性、处方实践和治疗反应。
AIDS Patient Care STDS. 2018 Feb;32(2):58-69. doi: 10.1089/apc.2017.0304.
10
Association of Human Immunodeficiency Virus Infection and Risk of Peripheral Artery Disease.人类免疫缺陷病毒感染与外周动脉疾病风险的关联。
Circulation. 2018 Jul 17;138(3):255-265. doi: 10.1161/CIRCULATIONAHA.117.032647. Epub 2018 Mar 13.

本文引用的文献

1
Statin treatment, new-onset diabetes, and other adverse effects: a systematic review.他汀类药物治疗、新发糖尿病及其他不良反应:系统评价。
Curr Cardiol Rep. 2014 Mar;16(3):461. doi: 10.1007/s11886-013-0461-4.
2
Systemic effects of inflammation on health during chronic HIV infection.慢性 HIV 感染期间炎症对健康的全身影响。
Immunity. 2013 Oct 17;39(4):633-45. doi: 10.1016/j.immuni.2013.10.001.
3
Progression of carotid intima-media thickness and coronary artery calcium over 6 years in an HIV-infected cohort.6 年内 HIV 感染队列的颈动脉内膜中层厚度和冠状动脉钙进展情况。
J Acquir Immune Defic Syndr. 2013 Sep 1;64(1):51-7. doi: 10.1097/QAI.0b013e31829ed726.
4
The incidence of AIDS-defining illnesses at a current CD4 count ≥ 200 cells/μL in the post-combination antiretroviral therapy era.在联合抗逆转录病毒治疗时代,当前 CD4 计数≥200 个/μL 时艾滋病定义性疾病的发病率。
Clin Infect Dis. 2013 Oct;57(7):1038-47. doi: 10.1093/cid/cit423. Epub 2013 Aug 6.
5
Metabolic syndrome predicts all-cause mortality in persons with human immunodeficiency virus.代谢综合征可预测人类免疫缺陷病毒感染者的全因死亡率。
AIDS Patient Care STDS. 2013 May;27(5):266-71. doi: 10.1089/apc.2012.0402.
6
Statin therapy and mortality in HIV-infected individuals; a Danish nationwide population-based cohort study.他汀类药物治疗与 HIV 感染者的死亡率:一项丹麦全国基于人群的队列研究。
PLoS One. 2013;8(3):e52828. doi: 10.1371/journal.pone.0052828. Epub 2013 Mar 4.
7
Comparative benefits of statins in the primary and secondary prevention of major coronary events and all-cause mortality: a network meta-analysis of placebo-controlled and active-comparator trials.他汀类药物在主要冠脉事件和全因死亡率的一级和二级预防中的比较获益:基于安慰剂对照和阳性药物对照试验的网络荟萃分析。
Eur J Prev Cardiol. 2013 Aug;20(4):641-57. doi: 10.1177/2047487313480435. Epub 2013 Feb 27.
8
Effect of statin therapy in reducing the risk of serious non-AIDS-defining events and nonaccidental death.他汀类药物治疗降低严重非艾滋病定义事件和非意外死亡风险的效果。
Clin Infect Dis. 2013 May;56(10):1471-9. doi: 10.1093/cid/cit053. Epub 2013 Feb 5.
9
Long-term survival in HIV positive patients with up to 15 Years of antiretroviral therapy.抗逆转录病毒治疗长达 15 年的 HIV 阳性患者的长期生存。
PLoS One. 2012;7(11):e48839. doi: 10.1371/journal.pone.0048839. Epub 2012 Nov 7.
10
The safety and effectiveness of statins as treatment for HIV-dyslipidemia: the evidence so far and the future challenges.他汀类药物治疗 HIV 血脂异常的安全性和有效性:迄今为止的证据和未来的挑战。
Expert Opin Pharmacother. 2012 Sep;13(13):1901-9. doi: 10.1517/14656566.2012.706604. Epub 2012 Jul 7.